Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30144% above fair value
$55.93+0.53 (+0.96%)
Close on Nov 13, 2026Market cap $3.34BP/E –Yield –
Axogen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Axogen's EV/EBITDA was 152.4× on Jan 30, 2026.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 152.4× | +9.2 |
| 2025 | Dec 31, 2025 | 143.2× | – |
See a number that looks wrong?